Food and Drug Administration Office of Criminal Investigations BOSTON – A Lynn man was sentenced yesterday in federal court in Boston for his role in a conspiracy to traffic counterfeit steroids, including testosterone and trenbolone, to customers across the country. Philip Goodwin, 37, was sentenced by U.S. District Court Judge Nathaniel M. Gorton to…
March 30, 2018: KC Paramedic Indicted for Stealing Fentanyl, Morphine from Ambulances
Food and Drug Administration Office of Criminal Investigations KANSAS CITY, Mo. – A Kansas City, Mo., Fire Department paramedic has been indicted by a federal grand jury for stealing fentanyl and morphine from ambulances and replacing fentanyl with another substance. Michael L. Fostich, 36, of Kansas City, Mo., was charged in a two-count indictment…
March 30, 2018: Counterfeit Cigarette Smuggler Sentenced to Prison
Food and Drug Administration Office of Criminal Investigations Benjamin G. Greenberg. United States Attorney for the Southern District of Florida and Justin D. Green, Special Agent in Charge, U.S. Food & Drug Administration, Office of Criminal Investigations (FDA OCI), Miami Field Office, made the announcement. Flores previously pled guilty to participating in a…
April 4, 2018: Fences Indicted in Multi-Million Dollar, Multi-State Criminal Theft Operations
Food and Drug Administration Office of Criminal Investigations HOUSTON – Two brothers are set to appear in court following the return of two indictments for their separate operations involving the possession and interstate transportation of stolen property, announced U.S. Attorney Ryan K. Patrick. A federal grand jury returned the indictments March 28, 2018, against…
April 4, 2018: Canadian Pharmacist Sentenced for Distributing Counterfeit and Adulterated Botox to Local Doctors
Food and Drug Administration Office of Criminal Investigations St. Louis, MO – Nikhil Buhecha, a resident of Vancouver, British Columbia, Canada, pled guilty today and was sentenced to 36 months’ imprisonment for conspiring to distribute counterfeit, misbranded, and adulterated Botox® into the United States, including multiple shipments to two doctors located in St….
March 27, 2018: Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud
Food and Drug Administration Office of Criminal Investigations BIRMINGHAM – A federal judge today sentenced the owner of a Decatur compounding pharmacy to five years in prison for conspiring to defraud a federal health insurance program out of more than $10 million. U.S. Attorney Jay E. Town, Food and Drug Administration, Office of Criminal…
March 27, 2018: Federal Jury Finds Three Guilty in Fentanyl Distribution Conspiracy
Food and Drug Administration Office of Criminal Investigations Massive Overdose Outbreak in Murfreesboro Left One Person Dead and More than 20 Hospitalized A federal jury in Nashville, Tennessee yesterday, returned guilty verdicts against three individuals on trial for their role in a deadly fentanyl distribution conspiracy, announced U.S. Attorney Don Cochran of the Middle…
About Warning and Close-Out Letters
This page reviews the types of warning letters found on the FDA website. General FDA Warning Letters When FDA finds that a manufacturer has significantly violated FDA regulations, FDA notifies the manufacturer. This notification is often in the form of a Warning Letter. The Warning Letter identifies the violation, such as poor manufacturing practices, problems…
Inspection Citation
On January 21, 2009, President Obama issued the Open Government Initiative. These data sets were created to provide public information regarding the various findings that result from inspections. The Agency is disclosing findings from these inspections to improve the public’s understanding of how the FDA works to protect the public health, provide the public with…
Inspection Classification Definitions
At the end of an inspection, observations made during an inspection are shared with the most responsible party at the firm in an FDA Form 483, Report of Observations. The determination of whether any condition or practice is violative is an Agency decision, made considering all inspectional and compliance input. An inspection classification may be…